Sign in to view content

Analysis of Retinal Fluid and Vision Outcomes in the Archway Phase 3 Trial of the Port Delivery System With Ranibizumab (PDS) in Patients With nAMD

Arshad M. Khanani, MD, MA, FASRS

Video
Published 2021

Related

Prophylactic Ranibizumab for Exudative AMD in Vulnerable Eyes With Nonexudative AMD Trial (PREVENT) A Prospective Controlled Clinical Trial
Maziar Lalezary, MD, FASRS
Annual Meeting Talks
2018
Updated Safety and Efficacy Results From the Archway Phase 3 Trial of the Port Delivery System With Ranibizumab (PDS) for Neovascular AMD
Carl C. Awh, MD, FASRS
Updates from the Field
2021
Episode 146: Journal Club Discussing PIVOT trial, FLUID trial, Timing of Macula-Off RDs
Jayanth Sridhar, MD
Member Podcasts
2018

Category: AMD-Neovascular

See more